Quadria Group Launches HealthQuad Fund III

HealthQuad Fund III, initiated by Quadria Group, a private equity platform focusing on healthcare, aims to raise as much as $300 million. This includes a target corpus of $200 million along with a $100 million greenshoe option. The third fund is designed to build upon the successes of HealthQuad Funds I and II, which have effectively identified and scaled innovative healthcare enterprises that significantly enhance access, affordability, and care quality across India.

This fund launch aligns with Quadria’s ongoing mission to establish India’s premier integrated healthcare investment platform, providing capital solutions from early-stage innovations to fully scaled growth throughout the healthcare value chain.

Established in 2016, HealthQuad was created as a dedicated investment entity aimed at supporting disruptive, technology-driven healthcare models during their early growth phases. Funds I and II have successfully invested in over 18 companies, including notable names like Qure.ai, Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences.

Expansion of Healthcare Investment Franchise

With the introduction of Fund III, Quadria is positioning itself to expand its healthcare investment franchise further. Following its separation from KOIS, Dr. Amit Varma, Abrar Mir, and Sunil Thakur will take full ownership and control of the platform. A significant part of the existing investment and committee team will continue to play a key role in the management of current portfolio investments.

Leveraging Institutional Networks

Quadria plans to utilise its global and domestic institutional investor network to bolster the fund and maximise its impact. The firm has recently concluded Quadria Capital Fund III at a substantial $1.07 billion, supported by leading global institutions.

Founded in 2012, Quadria Capital oversees an impressive portfolio exceeding $4 billion in assets across 27 investments in South and Southeast Asia, notably in India, Vietnam, Indonesia, Malaysia, and Singapore. The firm is dedicated to generating sustainable value by collaborating with high-impact healthcare businesses and ensuring robust returns for investors.